Philip Buergin

Philip Buergin is a seasoned professional with extensive experience in private equity, consulting, and leadership roles within the dental and healthcare sectors. Currently serving as a Board Member for Sun Wave Pharma and Principal at LetterOne, Philip Buergin also holds the position of Chairman at SHS Holdings. Previous roles include Chief Executive Officer at Colosseum Dental UK Ltd and Board Observer at Colosseum Dental Group. Philip Buergin has a strong background in private equity from positions at Jacobs Holding AG and Bain & Company, and began a career in investment banking at Goldman Sachs. Educational qualifications include a Program for Leadership Development from Harvard Business School, an MBA from Columbia Business School, and a Master of Arts in Finance from the University of St.Gallen. An exchange program at the Indian Institute of Management Bangalore added to Philip Buergin's diverse academic foundation.